Agilent Technologies, Inc. (A) Position Increased by WCM Investment Management CA
WCM Investment Management CA lifted its position in Agilent Technologies, Inc. (NYSE:A) by 8.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 721,036 shares of the medical research company’s stock after buying an additional 56,589 shares during the period. Agilent Technologies comprises 0.6% of WCM Investment Management CA’s holdings, making the stock its 27th largest position. WCM Investment Management CA owned 0.22% of Agilent Technologies worth $46,290,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Dupont Capital Management Corp bought a new position in Agilent Technologies during the 3rd quarter worth about $101,000. Balentine LLC increased its holdings in Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares in the last quarter. Sun Life Financial INC increased its holdings in Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC increased its holdings in Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Parallel Advisors LLC increased its holdings in Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares in the last quarter.
Shares of Agilent Technologies, Inc. (A) traded up $0.32 during trading hours on Tuesday, reaching $67.13. 1,536,300 shares of the company traded hands, compared to its average volume of 1,820,754. Agilent Technologies, Inc. has a twelve month low of $42.92 and a twelve month high of $68.67. The firm has a market cap of $21,600.00, a P/E ratio of 29.17, a P/E/G ratio of 2.62 and a beta of 1.28. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.22 and a quick ratio of 2.76.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period last year, the business posted $0.49 EPS. Agilent Technologies’s revenue was up 6.7% on a year-over-year basis. equities research analysts anticipate that Agilent Technologies, Inc. will post 2.32 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd were paid a $0.132 dividend. The ex-dividend date was Monday, October 2nd. This represents a $0.53 annualized dividend and a yield of 0.79%. Agilent Technologies’s dividend payout ratio (DPR) is currently 27.32%.
In related news, insider Dominique Grau sold 13,007 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $62.00, for a total value of $806,434.00. Following the completion of the sale, the insider now directly owns 60,098 shares in the company, valued at approximately $3,726,076. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mark Doak sold 12,421 shares of the firm’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The disclosure for this sale can be found here. Insiders sold a total of 165,720 shares of company stock valued at $10,488,739 over the last quarter.
A number of equities analysts have issued reports on A shares. Barclays PLC reiterated a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a report on Wednesday, July 19th. BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Jefferies Group LLC reiterated a “buy” rating and set a $66.00 target price on shares of Agilent Technologies in a report on Wednesday, August 9th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, August 16th. Finally, Bank of America Corporation reiterated an “equal weight” rating on shares of Agilent Technologies in a report on Tuesday, August 15th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $66.70.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.